Incidence of human granulocytic anaplasmosis in returning travellers with fever.

Anaplasma phagocytophilum doxycycline emerging infections fever ticks travel vector-borne diseases

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 08 02 2021
revised: 23 03 2021
accepted: 31 03 2021
pubmed: 12 4 2021
medline: 10 8 2021
entrez: 11 4 2021
Statut: ppublish

Résumé

Although tick-borne pathogens have been reported as an important cause of imported fever, the incidence of Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis (HGA), in travellers is unknown. We conducted a prospective cohort study to investigate the aetiologies of fever in returning travellers (November 2017-July 2019). Polymerase chain reaction for msp2 gene amplification and indirect immunofluorescence assay for A. phagocitophilum were performed in all returning travellers with undifferentiated non-malarial fever. Among 141 travellers included, 8 patients were diagnosed with probable or confirmed HGA. The overall incidence rate of HGA was 19.9 cases/1000 person-week of travel. The main destination of travel was Asia, accounting for 62.5% patients with HGA. Co-infections were found in 37.5% of patients with HGA. Diagnosis of HGA and empirical treatment with doxycycline should be considered in travellers with fever.

Sections du résumé

BACKGROUND
Although tick-borne pathogens have been reported as an important cause of imported fever, the incidence of Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis (HGA), in travellers is unknown.
METHODS
We conducted a prospective cohort study to investigate the aetiologies of fever in returning travellers (November 2017-July 2019). Polymerase chain reaction for msp2 gene amplification and indirect immunofluorescence assay for A. phagocitophilum were performed in all returning travellers with undifferentiated non-malarial fever.
RESULTS
Among 141 travellers included, 8 patients were diagnosed with probable or confirmed HGA. The overall incidence rate of HGA was 19.9 cases/1000 person-week of travel. The main destination of travel was Asia, accounting for 62.5% patients with HGA. Co-infections were found in 37.5% of patients with HGA.
CONCLUSIONS
Diagnosis of HGA and empirical treatment with doxycycline should be considered in travellers with fever.

Identifiants

pubmed: 33839778
pii: 6218787
doi: 10.1093/jtm/taab056
pii:
doi:

Substances chimiques

Doxycycline N12000U13O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© International Society of Travel Medicine 2021. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Daniel Camprubí-Ferrer (D)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Aránzazu Portillo (A)

Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, 26006 Logroño, Spain.

Sonia Santibáñez (S)

Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, 26006 Logroño, Spain.

Alejandro Almuedo-Riera (A)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Natalia Rodriguez-Valero (N)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Carme Subirà (C)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Miguel J Martinez (MJ)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Jessica Navero-Castillejos (J)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Marc Fernandez-Pardos (M)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Blaise Genton (B)

Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland.
Center for Primary Care and Public Health, University of Lausanne, 1010, Switzerland.

Ludovico Cobuccio (L)

Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland.

Steven Van Den Broucke (S)

Institute of Tropical Medicine, 2000 Antwerp, Belgium.

Emmanuel Bottieau (E)

Institute of Tropical Medicine, 2000 Antwerp, Belgium.

Jose Muñoz (J)

ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

José Antonio Oteo (JA)

Center of Rickettsiosis and Arthropod-Borne Diseases, Hospital Universitario San Pedro-CIBIR, 26006 Logroño, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH